No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation

Journal of General Virology

Volumn 78, Issue 10, 1997, Pages 2523-2528

  Dittmer, Ulf ^a,c   Nißlein, Thomas ^a   Meyerhans, Andreas ^b   Hunsmann, Gerhard ^a   Stahl Hennig, Christiane ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MACACA; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VACCINIA VIRUS; VIRUS ACTIVATION; VIRUS ATTENUATION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0030812550     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-10-2523     Document Type: Article

References (26)

1. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B. & Stott, E. J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344.
2. Baba, T. W., Jeong, Y. S., Penninck, D., Bronson R., Greene, M. F. & Ruprecht, R. M. (1995). Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
3. Corey, L. (1995). Reducing T-cell activation as a therapy for human immunodeficiency virus infection. Journal of Infectious Diseases 171, 521-522.
4. Cranage, M. P., Cook, N., Johnstone, P., Greenaway, P., Kitchin, P. A., Stott, E. J., Almond, N. & Baskerville, A. (1990). SIV infection of rhesus macaques: in vitro titration of infectivity and development of an experimental vaccine. In Animal Models in AIDS, pp. 103-114. Edited by H. Schnellkens. Amsterdam: Elsevier.
5. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effect of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
6. Demkowicz, W. E., Shin Maa, J. & Esteban, M. (1992). Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. Journal of Virology 66, 386-398.
7. Dittmer, U., Nißlein, T., Bodemer, W., Petry, H., Sauermann, U., Stahl-Hennig, C. & Hunsmann, G. (1995). Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212, 392-397.
8. Goletti, D., Weissman, D., Jackson, R. W., Graham, N. M. H., Vlahov, D., Klein, R. S., Munsiff, S. S., Ortona, L., Cauda, R. & Fauci, A. S. (1996). Effect of Mycobacterium tuberculosis on HIV replication. Journal of Immunology 157, 1271-1278.
9. Igarashi, R., Shibata, R., Hasebe, F., Ami, Y., Shinohara, K., Komatsu, T., Stahl-Hennig, C., Petry, H., Hunsmann, G., Kuwata, T., Jin, M., Adachi, A., Kurimura, T., Okada, M., Miura, T. & Hayami, M. (1994). Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Research and Human Retroviruses 10, 1021-1029.
10. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
11. Kornfeld, H., Cruikshank, W. W., Pyle, S. W., Berman, J. S. & Center, D. M. (1988). Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 355, 445-449.
12. Kuwata, T., Igarashi, T., Ido, E., Jin, M., Mizuno, A., Chen, J. & Hayami, M. (1995). Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. Journal of General Virology 76, 2181-2191.
13. Kuwata, T., Shioda, T., Igarashi, T., Ido, E., Ibuki, K., Enose, Y., Stahl-Hennig, C., Hunsmann, G., Tomoyuki, M. & Hayami, M. (1996). Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS 10, 1331-1337.
14. Li, J. T., Halloran, M., Lord, C. I., Watson, A., Ranchalis, J., Fung, M., Letvin, N. L. & Sodroski, J. G. (1995). Persistent infection of macaques with simian-human immunodeficiency viruses. Journal of Virology 69, 7061-7071.
15. Norley, S., Beer, B., Binninger-Schinzel, D., Cosma, C. & Kurth, R. (1996). Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 219, 195-205.
16. O'Brien, W. A., Grovit-Ferbas, K., Namazi, A., Ovcak-Derzic, S., Wang, H. J., Park, J., Yeramian, C., Mao, S. H. & Zack, J. A. (1995). Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86, 1082-1089.
17. Regier, D. A. & Desrosiers, R. C. (1990). The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Research and Human Retroviruses 6, 1221-1231.
18. + individuals. Clinical and Experimental Immunology 104, 203-207.
19. Rud, E. W., Cranage, M., Yon, J., Quirk, J., Ogilve, L., Cook, N., Webster, S., Dennis, M. & Clarke, B. E. (1994). Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. Journal of General Virology 75, 529-543.
20. Schäffner, J.-W., Dittmer, U., Otteken, A., Coulibaly, C., Bodemer, W., Voss, G. & Hunsmann, G. (1994). Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques. American Journal of Veterinary Research 55, 1250-1255.
21. Stahl-Hennig, C., Dittmer, U., Nißlein, T., Petry, H., Jurkiewicz, E., Fuchs, D., Wachter, H., Mätz-Rensing, K., Kuhn, E.-M., Kaup, F.-J., Rud, E. W. & Hunsmann, G. (1996). Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. Journal of General Virology 77, 2969-2981.
22. Stanley, S. K., Ostrowski, M. A., Justement, J. S., Gantt, K., Hedayati, S., Mannix, M., Roche, K., Schwartzentruber, D. J., Fox, C. H. & Fauci, A. S. (1996). Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. New England Journal of Medicine 334, 1222-3230.
23. Staprans, S. I., Hamilton, B. L., Follansbee, S. E., Elbeik, T., Barbosa, P., Grant, R. M. & Feinberg, M. B. (1995). Activation of virus replication after vaccination of HIV-1-infected individuals. Journal of Experimental Medicine 182, 1727-1737.
24. Villinger, F., Folks, T. M., Lauro, S., Powell, J. D., Sundstrom, J. B., Mayne, A. & Ansari, A. A. (1996). Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunology Letters 51, 59-68.
25. Voss, G., Dittmer, U., Coulibaly, C., Makoschey, B., Retry, H., Leuke, W. and Hunsmann, G. (1994). Differences in the B and T cell immune responses to the envelope glycoprotein 130 of the macaque strain of simian immunodeficiency virus, induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130. Journal of General Virology 74, 1757-1763.
26. Whatmore, A. M., Cook, N., Hall, G. H., Sharpe, S., Rud, E. W. & Cranage, M. P. (1995). Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69, 5117-5123.